PE28097A1 - Procedimiento para preparar monohidrato de loracarbef - Google Patents
Procedimiento para preparar monohidrato de loracarbefInfo
- Publication number
- PE28097A1 PE28097A1 PE1996000129A PE00012996A PE28097A1 PE 28097 A1 PE28097 A1 PE 28097A1 PE 1996000129 A PE1996000129 A PE 1996000129A PE 00012996 A PE00012996 A PE 00012996A PE 28097 A1 PE28097 A1 PE 28097A1
- Authority
- PE
- Peru
- Prior art keywords
- procedure
- prepare
- give
- drying
- equal
- Prior art date
Links
- GPYKKBAAPVOCIW-HSASPSRMSA-N (6r,7s)-7-[[(2r)-2-amino-2-phenylacetyl]amino]-3-chloro-8-oxo-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid;hydrate Chemical compound O.C1([C@H](C(=O)N[C@@H]2C(N3C(=C(Cl)CC[C@@H]32)C(O)=O)=O)N)=CC=CC=C1 GPYKKBAAPVOCIW-HSASPSRMSA-N 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000001035 drying Methods 0.000 abstract 2
- 238000009472 formulation Methods 0.000 abstract 1
- 229960001977 loracarbef Drugs 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 150000004682 monohydrates Chemical class 0.000 abstract 1
- OGHBATFHNDZKSO-UHFFFAOYSA-N propan-2-olate Chemical compound CC(C)[O-] OGHBATFHNDZKSO-UHFFFAOYSA-N 0.000 abstract 1
- 239000002904 solvent Substances 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D463/00—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D463/10—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
- C07D463/14—Heterocyclic compounds containing 1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbacephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hetero atoms directly attached in position 7
- C07D463/16—Nitrogen atoms
- C07D463/18—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof
- C07D463/20—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
- C07D463/22—Nitrogen atoms further acylated by radicals derived from carboxylic acids or by nitrogen or sulfur analogues thereof with the acylating radicals further substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen further substituted by nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Abstract
SE REFIERE AL PROCEDIMENTO PARA PREPARAR UNA FORMA CRISTALINA MONOHIDRATADA DE LORACARBEF DE FORMULA I, QUE COMPRENDE: A)SECAR LA FORMA CRISTALINA DE ISOPROPANOLATO DEL COMPUESTO DE FORMULA I DE 50�C A 100�C, PARA DAR UNA FORMA ANHIDRA; B)EXPONERLA A HUMEDAD RELATIVA DE 90% A 100%, PARA DAR UNA FORMA MONOHIDRATADA, CON UN CONTENIDO DE AGUA MAYOR O IGUAL A 10%; C) SECARLA DE 55�C A 75�C Y 20 mbar; OBTENIENDOSE UN MONOHIDRATO CON UNA DENSIDAD APARENTE MAYOR O IGUAL A 0.5 g/ml Y CON UN CONTENIDO DE ISOPROPANOLOL RESIDUAL MENOR A 1% (EN PESO), LO CUAL DISMINUYE EL SOLVENTE AL NIVEL ACEPTADO EN SERES HUMANOS, ELEVA LA DENSIDAD APARENTE Y EVITA LA REHIDRATACION, MEJORANDO SU CAPACIDAD DE FORMULACION
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/396,948 US5580977A (en) | 1995-03-01 | 1995-03-01 | Process for preparing loracarbef monohydrate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE28097A1 true PE28097A1 (es) | 1997-08-20 |
Family
ID=23569249
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE1996000129A PE28097A1 (es) | 1995-03-01 | 1996-02-26 | Procedimiento para preparar monohidrato de loracarbef |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US5580977A (es) |
| EP (1) | EP0729959B1 (es) |
| JP (1) | JPH11501032A (es) |
| KR (1) | KR19980702666A (es) |
| CN (1) | CN1061349C (es) |
| AR (1) | AR002709A1 (es) |
| AT (1) | ATE184006T1 (es) |
| AU (1) | AU694639B2 (es) |
| BR (1) | BR9607308A (es) |
| CA (1) | CA2213812A1 (es) |
| CO (1) | CO4700429A1 (es) |
| CZ (1) | CZ272897A3 (es) |
| DE (1) | DE69603995T2 (es) |
| DK (1) | DK0729959T3 (es) |
| ES (1) | ES2135165T3 (es) |
| GR (1) | GR3031947T3 (es) |
| HU (1) | HUP9702151A3 (es) |
| IL (1) | IL117228A (es) |
| NO (1) | NO308471B1 (es) |
| NZ (1) | NZ304534A (es) |
| PE (1) | PE28097A1 (es) |
| PL (1) | PL322111A1 (es) |
| RU (1) | RU2160261C2 (es) |
| SI (1) | SI0729959T1 (es) |
| TR (1) | TR199700877T1 (es) |
| TW (1) | TW330205B (es) |
| WO (1) | WO1996026942A1 (es) |
| ZA (1) | ZA961341B (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100540046B1 (ko) | 1997-11-12 | 2006-01-10 | 미쓰비시 가가꾸 가부시키가이샤 | 퓨린유도체 및 이를 유효성분으로 함유하는 의약 |
| JP3956188B2 (ja) | 1999-05-11 | 2007-08-08 | 三菱化学株式会社 | プリン誘導体２水和物、それを有効成分として含む医薬およびその製造中間体 |
| US6410520B2 (en) | 2000-02-01 | 2002-06-25 | The Procter & Gamble Company | Selective crystallization of 3-pyridyl-1-hydroxyethylidene-1, 1-bisphosphonic acid sodium as the hemipentahydrate or monohydrate |
| PE20011065A1 (es) | 2000-02-01 | 2001-11-21 | Procter & Gamble | Proceso para fabricar bisfosfonatos geminales |
| US20060205938A1 (en) * | 2002-11-21 | 2006-09-14 | Yatendra Kumar | Monohydrate solvates of loracarbef |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3531481A (en) * | 1969-04-21 | 1970-09-29 | Lilly Co Eli | Method for manufacture of crystalline cephalosporin |
| US3502663A (en) * | 1969-04-21 | 1970-03-24 | Lilly Co Eli | Crystalline cephalosporin,method for its manufacture |
| US4775751A (en) * | 1985-06-03 | 1988-10-04 | Eli Lilly & Company | Process for cephalexin hydrochloride alcoholates |
| YU46699B (sh) * | 1987-10-06 | 1994-04-05 | Eli Lilly And Co. | Kristalni monohidratni oblik 1-karbacefalosporina |
| US4977257A (en) * | 1988-11-14 | 1990-12-11 | Eli Lilly And Company | DMF solvates of a β-lactam antibiotic |
| CA2002596A1 (en) * | 1988-11-14 | 1990-05-14 | Thomas M. Eckrich | Hydrates of b-lactam antibiotic |
| CA2002597C (en) * | 1988-11-14 | 1999-03-23 | Thomas M. Eckrich | Solvates of b-lactam antibiotic |
| US5352782A (en) * | 1993-06-04 | 1994-10-04 | Eli Lilly And Company | Process for preparing crystalline β-lactam monohydrate |
| US5399686A (en) * | 1993-06-04 | 1995-03-21 | Eli Lilly And Company | Loracarbef isopropanolate and a process for converting loracarbef isopropanolate to loracarbef monohydrate |
| US5374719A (en) * | 1993-06-04 | 1994-12-20 | Eli Lilly And Company | Process for converting loracarbef dihydrate to loracarbef monohydrate |
-
1995
- 1995-03-01 US US08/396,948 patent/US5580977A/en not_active Expired - Lifetime
-
1996
- 1996-02-20 ZA ZA9601341A patent/ZA961341B/xx unknown
- 1996-02-21 AR ARP960101460A patent/AR002709A1/es not_active Application Discontinuation
- 1996-02-22 IL IL11722896A patent/IL117228A/xx active IP Right Grant
- 1996-02-24 TW TW085102100A patent/TW330205B/zh active
- 1996-02-26 PE PE1996000129A patent/PE28097A1/es not_active Application Discontinuation
- 1996-02-26 CO CO96008863A patent/CO4700429A1/es unknown
- 1996-02-27 ES ES96301303T patent/ES2135165T3/es not_active Expired - Lifetime
- 1996-02-27 SI SI9630108T patent/SI0729959T1/xx not_active IP Right Cessation
- 1996-02-27 EP EP96301303A patent/EP0729959B1/en not_active Expired - Lifetime
- 1996-02-27 AT AT96301303T patent/ATE184006T1/de not_active IP Right Cessation
- 1996-02-27 DE DE69603995T patent/DE69603995T2/de not_active Expired - Fee Related
- 1996-02-27 DK DK96301303T patent/DK0729959T3/da active
- 1996-02-28 BR BR9607308A patent/BR9607308A/pt not_active Application Discontinuation
- 1996-02-28 CN CN96193438A patent/CN1061349C/zh not_active Expired - Fee Related
- 1996-02-28 NZ NZ304534A patent/NZ304534A/en unknown
- 1996-02-28 JP JP8526365A patent/JPH11501032A/ja not_active Ceased
- 1996-02-28 KR KR1019970706072A patent/KR19980702666A/ko not_active Abandoned
- 1996-02-28 AU AU51742/96A patent/AU694639B2/en not_active Ceased
- 1996-02-28 PL PL96322111A patent/PL322111A1/xx unknown
- 1996-02-28 TR TR97/00877T patent/TR199700877T1/xx unknown
- 1996-02-28 CA CA002213812A patent/CA2213812A1/en not_active Abandoned
- 1996-02-28 WO PCT/US1996/002586 patent/WO1996026942A1/en not_active Ceased
- 1996-02-28 HU HU9702151A patent/HUP9702151A3/hu unknown
- 1996-02-28 CZ CZ972728A patent/CZ272897A3/cs unknown
- 1996-02-28 RU RU97116165/04A patent/RU2160261C2/ru active
-
1997
- 1997-08-20 NO NO973835A patent/NO308471B1/no not_active IP Right Cessation
-
1999
- 1999-11-25 GR GR990403040T patent/GR3031947T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20010053A1 (es) | Formulacion de amoxicilina y clavulanato de potasio | |
| SV2002000250A (es) | Formula de dosis de droga accionada por hidrogel ref. pc10818ajtb/bb | |
| DE3883016D1 (de) | Komplexe verbindungen aus bioflavonoiden mit phospholipiden, ihre herstellung und verwendung und sie enthaltende pharmazeutische und kosmetische zusammensetzungen. | |
| FI854128L (fi) | Foerfarande foer framstaellning av en foedoaemneskomposition som innehaoller inosotoltrifosfat och denna komposition. | |
| ES2113867T3 (es) | Imino-derivados ciclicos, medicamentos que contienen estos compuestos y procedimiento para su preparacion. | |
| ES2147739T3 (es) | Fosfonooximetil-eteres de derivados de taxano. | |
| ES2059729T5 (es) | Preparado farmaceutico de liberacion controlada y metodo para producir el mismo. | |
| ES2070276T3 (es) | Lactonas macrociclicas inhibidoras del crecimiento celular denominadas combretastatina d-2. | |
| ES2163291T3 (es) | Composiciones farmaceuticas que contienen eletriptan hemisulfato y cafeina. | |
| ATE69817T1 (de) | Tetraoxodiazabicyclo-(3,3,1)-nonane. | |
| ATE82139T1 (de) | Eine lipidloesliche substanz enthaltende waessrige fluessigkeit. | |
| IT1212141B (it) | Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare. | |
| ATE108437T1 (de) | Substituierte diaminophthalimide und analoga. | |
| PE28097A1 (es) | Procedimiento para preparar monohidrato de loracarbef | |
| SE8704952L (sv) | Farmaceutisk komposition | |
| IT1241079B (it) | Composizioni farmaceutiche contenenti ipriflavone,procedimento per la loro preparazione e relativo impiego terapeutico | |
| GT198400146A (es) | Nuevos derivados de cefalosporina. | |
| ES2067206T3 (es) | Composiciones farmaceuticas conteniendo 3-amino-epsilon-caprolactamas para estimular el proceso de aprendizaje y la memoria. | |
| SE7901203L (sv) | O-substituerade oximderivat av 7-amino-tiazolyl-acetamido-cefalosporansyra, sett for framstellning och anvendning derav som lekemedel samt farmaceutiska kompositioner innehallande dessa foreningar | |
| NO167978C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive tetrahydro-benzotiazoler. | |
| ES2081282T3 (es) | Estabilizacion de polifenileneteres con compuestos de polialquilpiperidina macrociclicos. | |
| IT943598B (it) | Processo per la preparazione di formulazioni stabili di nadh | |
| CO4480739A1 (es) | Formas zwitterionicas de trovafloxacina | |
| IT1255982B (it) | Composti di inclusione di nimesulide con ciclodestrina e procedimento per la preparazione di tali composti | |
| ECSP045041A (es) | Uso de una dosis especifica de fondaparinux sodio para el tratamiento de los sindromes coronarios agudos |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |